Bansi Desai
Stock Analyst at J.P. Morgan
(2.44)
# 2,972
Out of 4,504 analysts
64
Total ratings
46.5%
Success rate
2.4%
Average return
Main Sectors:
Stocks Rated by Bansi Desai
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: ALKEM Alkem Laboratories Limited | Maintained: Hold | ₹6,400 → ₹5,900 | $5,676.00 | +3.95% | 5 | May 29, 2026 | |
| NSE: BLUEJET Blue Jet Healthcare Limited | Maintained: Sell | ₹600.00 → ₹370.00 | $622.40 | -40.55% | 4 | May 27, 2026 | |
| NSE: FORTIS Fortis Healthcare Limited | Maintained: Buy | ₹1,050 → ₹1,120 | $969.00 | +15.58% | 5 | May 27, 2026 | |
| NSE: DIVISLAB Divi's Laboratories Limited | Maintained: Buy | ₹7,800 → ₹7,400 | $6,830.50 | +8.34% | 2 | May 25, 2026 | |
| NSE: MANKIND Mankind Pharma Limited | Maintained: Buy | ₹2,800 → ₹2,850 | $2,528.00 | +12.74% | 6 | May 22, 2026 | |
| NSE: ZYDUSLIFE Zydus Lifesciences Limited | Maintained: Hold | ₹1,010 → ₹1,050 | $1,152.90 | -8.93% | 4 | May 22, 2026 | |
| NSE: ANTHEM Anthem Biosciences Limited | Maintained: Buy | ₹780.00 → ₹850.00 | $754.95 | +12.59% | 3 | May 22, 2026 | |
| NSE: CIPLA Cipla Limited | Maintained: Buy | ₹1,780 → ₹1,550 | $1,442.00 | +7.49% | 5 | May 18, 2026 | |
| NSE: LUPIN Lupin Limited | Maintained: Buy | ₹2,550 → ₹2,600 | $2,495.90 | +4.17% | 5 | Nov 9, 2025 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Maintained: Sell | ₹1,090 → ₹1,150 | $1,246.50 | -7.74% | 4 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹34,500 → ₹37,000 | $27,300.00 | +35.53% | 5 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,350 → ₹1,550 | $1,805.00 | -14.13% | 3 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,240 → ₹1,480 | $1,334.90 | +10.87% | 2 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,030 → ₹1,970 | $1,932.90 | +1.92% | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,700 → ₹1,840 | $1,458.00 | +26.20% | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,390 → ₹1,325 | $1,107.90 | n/a | 2 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹8,800 | $8,850.00 | n/a | 1 | Feb 12, 2025 |
Alkem Laboratories Limited
May 29, 2026
Maintained: Hold
Price Target: ₹6,400 → ₹5,900
Current: $5,676.00
Upside: +3.95%
Blue Jet Healthcare Limited
May 27, 2026
Maintained: Sell
Price Target: ₹600.00 → ₹370.00
Current: $622.40
Upside: -40.55%
Fortis Healthcare Limited
May 27, 2026
Maintained: Buy
Price Target: ₹1,050 → ₹1,120
Current: $969.00
Upside: +15.58%
Divi's Laboratories Limited
May 25, 2026
Maintained: Buy
Price Target: ₹7,800 → ₹7,400
Current: $6,830.50
Upside: +8.34%
Mankind Pharma Limited
May 22, 2026
Maintained: Buy
Price Target: ₹2,800 → ₹2,850
Current: $2,528.00
Upside: +12.74%
Zydus Lifesciences Limited
May 22, 2026
Maintained: Hold
Price Target: ₹1,010 → ₹1,050
Current: $1,152.90
Upside: -8.93%
Anthem Biosciences Limited
May 22, 2026
Maintained: Buy
Price Target: ₹780.00 → ₹850.00
Current: $754.95
Upside: +12.59%
Cipla Limited
May 18, 2026
Maintained: Buy
Price Target: ₹1,780 → ₹1,550
Current: $1,442.00
Upside: +7.49%
Lupin Limited
Nov 9, 2025
Maintained: Buy
Price Target: ₹2,550 → ₹2,600
Current: $2,495.90
Upside: +4.17%
Dr. Reddy's Laboratories Limited
Aug 19, 2025
Maintained: Sell
Price Target: ₹1,090 → ₹1,150
Current: $1,246.50
Upside: -7.74%
Aug 15, 2025
Maintained: Buy
Price Target: ₹34,500 → ₹37,000
Current: $27,300.00
Upside: +35.53%
Aug 11, 2025
Maintained: Hold
Price Target: ₹1,350 → ₹1,550
Current: $1,805.00
Upside: -14.13%
Aug 11, 2025
Maintained: Hold
Price Target: ₹1,240 → ₹1,480
Current: $1,334.90
Upside: +10.87%
Aug 1, 2025
Maintained: Buy
Price Target: ₹2,030 → ₹1,970
Current: $1,932.90
Upside: +1.92%
Jul 29, 2025
Maintained: Buy
Price Target: ₹1,700 → ₹1,840
Current: $1,458.00
Upside: +26.20%
May 22, 2025
Maintained: Buy
Price Target: ₹1,390 → ₹1,325
Current: $1,107.90
Upside: n/a
Feb 12, 2025
Maintained: Buy
Price Target: ₹8,800
Current: $8,850.00
Upside: n/a